[HTML][HTML] A randomized trial of adjuvant chemotherapy with uracil–tegafur for adenocarcinoma of the lung

…, H Tada, Y Watanabe, H Wada… - … England Journal of …, 2004 - Mass Medical Soc
Background In a previous phase 3 trial of adjuvant chemotherapy after resection of non–small-cell
lung cancer, a combination of uracil and tegafur (often referred to as UFT) taken orally …

Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors

…, H Oka, O Yoshida, Y Shimada, S Ari-i, H Wada… - Oncogene, 1999 - nature.com
The 41-kDa and 43-kDa mitogen-activated protein (MAP) kinases play a pivotal role in the
mitogenic signal transduction pathway and are essential components of the MAP kinase …

[HTML][HTML] Thioredoxin‐2 (TRX‐2) is an essential gene regulating mitochondria‐dependent apoptosis

…, S Ueda, A Nishiyama, S Takeda, H Wada… - The EMBO …, 2002 - embopress.org
Thioredoxin‐2 (Trx‐2) is a mitochondria‐specific member of the thioredoxin superfamily.
Mitochondria have a crucial role in the signal transduction for apoptosis. To investigate the …

Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody

…, M Li, T Yamada, N Hanaoka, K Inui, H Wada - Clinical Cancer …, 2001 - AACR
Purpose: Angiogenesis is an essential process in the progression of malignant tumors.
Whereas pan-endothelial markers, such as CD34, are generally used in evaluation of …

Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non–small-cell lung cancer

…, K Kodama, M Imaizumi, H Wada - Journal of Clinical …, 2005 - ascopubs.org
Purpose Recent clinical trials have shown the efficacy of platinum-based adjuvant chemotherapy
for completely resected non–small-cell lung cancer (NSCLC). In Japan, many clinical …

Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery.

H Wada, S Hitomi, T Teramatsu - Journal of clinical oncology, 1996 - ascopubs.org
PURPOSE We performed a study to determine whether postoperative mild chemotherapy to
maintain the patient's quality of life (QOL) and immunoactivity could also prolong survival. …

[HTML][HTML] Thirty-day operative mortality for thoracotomy in lung cancer

H Wada, T Nakamura, K Nakamoto, M Maeda… - The Journal of thoracic …, 1998 - Elsevier
Objective: The 30-day operative mortality for thoracotomy in lung cancer is described herein.
Methods: From January 1994 through December 1994, the Japanese Association for Chest …

[18F] FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung

…, Y Nakamoto, K Yanagihara, M Li, F Tanaka, H Wada… - Neoplasia, 2005 - Elsevier
PURPOSE: The aim of this study was to evaluate the relationships among [ 18 F]fluorodeoxyglucose
([ 18 F]-FDG) uptake, Glut-1 and HK-II expressions, and grade of inflammation in …

GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion

…, Y Mazaki, H Kodama, Y Nio, T Manabe, H Wada… - Nature cell …, 2008 - nature.com
Epidermal growth factor (EGF) receptor (EGFR) signalling is implicated in tumour invasion
and metastasis 1 , 2 . However, whether there are EGFR signalling pathways specifically used …

Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities

…, M Adachi, T Sakurai, T Manabe, H Wada… - The EMBO …, 2005 - embopress.org
Identification of the molecular machinery employed in cancer invasion, but not in normal adult
cells, will greatly contribute to cancer therapeutics. Here we found that an ArfGAP, AMAP1/…